A Rapid Triage Test to Improve Risk-stratification of Febrile Children (EChiLiBRiST, Clinical Trial 1, Outpatients)
Recruiting
N/A
Interventional Study
Infectious Disease
Febrile Illness
Child, Only
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 2 Months – 60 Months
- Sex
- Any
- Study type
- Interventional
- Purpose
- Other
- Participants needed
- 5,212 (estimated)
- Sponsor
- Barcelona Institute for Global Health · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The overall aim of the study is to provide evidence that introducing novel biomarkers evaluation at triaging (first clinical assessment), in combination with IMCI-based guidelines (SoC), is a viable strategy to enhance rapid and accurate identification of febrile children at increased risk of life-threatening infections compared to IMCI-based strategies alone (SoC), and to demonstrate whether this…
Trial Locations
Sorted by distance from Connecticut
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥2 months and \<60 months
* Written informed consent from the child's parent or caregiver
* History of fever for ≤7 days OR hypothermia (i.e., axillary temperature \<35.5ºC) OR suspected severe infection (e.g., in children with moderate or severe acute malnutrition).
* Liv…
Contacts